<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778969</url>
  </required_header>
  <id_info>
    <org_study_id>E-2009-016-1154</org_study_id>
    <nct_id>NCT04778969</nct_id>
  </id_info>
  <brief_title>Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database</brief_title>
  <official_title>Coronary Artery Disease Patients Treated With Percutaneous Coronary Intervention: Analysis of the Korean Nationwide Health Insurance Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current Status and Prognosis of Coronary artery disease patients treated with coronary&#xD;
      intervention - Analysis of the Korean Nationwide Health Insurance Database&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective study and is conducted for all patients who received percutaneous&#xD;
      coronary intervention among cohorts registered with the National Health Insurance Service.&#xD;
&#xD;
      Primary outcome is all cause of mortality. Secondary outcomes are cardiovascular death,&#xD;
      ischemic stroke, cerebral hemorrhage, admission due to gastrointestinal bleeding, and&#xD;
      admission due to major bleedings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause of death</measure>
    <time_frame>10 years</time_frame>
    <description>'All cause of death' will be recorded as number of participants with 'All cause of death'</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>10 years</time_frame>
    <description>'Cardiovascular death' will be recorded as number of participants with 'Cardiovascular death'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ischemic stroke</measure>
    <time_frame>10 years</time_frame>
    <description>'ischemic stroke' will be recorded as number of participants with 'ischemic stroke'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral hemorrhage</measure>
    <time_frame>10 years</time_frame>
    <description>'Cerebral hemorrhage' will be recorded as number of participants with 'Cerebral hemorrhage'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission due to gastrointestinal bleeding</measure>
    <time_frame>10 years</time_frame>
    <description>'Admission due to gastrointestinal bleeding' will be recorded as number of participants with 'Admission due to gastrointestinal bleeding'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission due to major bleeding</measure>
    <time_frame>10 years</time_frame>
    <description>'Admission due to major bleeding' will be recorded as number of participants with 'Admission due to major bleeding' Thismeasure is a composite outcome, which includes cerebral hemorrhage, admission due to gastrointestinal bleeding.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Drug-eluting Stents</condition>
  <condition>Drug-coated Balloon</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug-eluting stent</intervention_name>
    <description>A group of percutaneous coronary intervention (PCI) using drug-eluting stents (DES)</description>
    <other_name>DES group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug-coated balloon</intervention_name>
    <description>A group of percutaneous coronary intervention (PCI) using drug-coated balloon (DCB)</description>
    <other_name>DCB group</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All coronary artery disease patients wih Korean NHIS (National Health Insurance&#xD;
        Service)-listed PCI Patients are selected based on the registered treatment insurance code.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All coronary artery disease patients wih Korean NHIS (National Health Insurance&#xD;
             Service)-listed PCI&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non-specified&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Han-Mo Yang, MD, PhD</last_name>
    <phone>8220722677</phone>
    <email>hanname@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hak Seung Lee, MD</last_name>
    <phone>821031668399</phone>
    <email>cardiolee@gmail.com</email>
  </overall_contact_backup>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>February 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 28, 2021</last_update_submitted>
  <last_update_submitted_qc>February 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Han-Mo Yang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Since this research is conducted with a national public institution, data cannot be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

